COMMUNIQUÉS West-GlobeNewswire

PRA Health Sciences to Report Second Quarter 2018 Earnings
12/07/2018
RALEIGH, N.C., July 12, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) will release its second quarter results after the market closes on Wednesday, August 1, 2018. The Company will also host a [...]
CROSSJECT annonce le principe d'une émission et de l'attribution gratuite de BSA aux actionnaires et le renforcement de sa structure financière par une nouvelle émission d'OC en actions de 2,5 M€
12/07/2018
Communiqué de Presse CROSSJECT ANNONCE LE PRINCIPE D'UNE EMISSION ET DE L'ATTRIBUTION GRATUITE DE BSA AUX ACTIONNAIRES ET LE RENFORCEMENT DE SA STRUCTURE FINANCIERE PAR UNE NOUVELLE EMISSION OBLIGATAIRE CONVERTIBLE EN [...]
GTX Corp Announces Update on Corporate Strategic Plan
12/07/2018
LOS ANGELES, July 12, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO) (“the Company”), a pioneer in the field of wearable GPS human and asset tracking systems and wandering assistive technology, announced today FINRA has [...]
The Alliance for Regenerative Medicine Announces Third and Final Reimbursement and Market Access-Focused White Paper in Three-Part Series Published in In Vivo
12/07/2018
WASHINGTON, D.C., July 12, 2018 (GLOBE NEWSWIRE) -- The Alliance for Regenerative Medicine (ARM) today announced the publication of its reimbursement and market-access focused white paper, “Moving From Chronic Therapies [...]
Emerald Health Therapeutics Updates on its Differentiated Strategy and Progress
12/07/2018
VICTORIA, British Columbia, July 12, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) (OTCQX:EMHTF) (Emerald) is providing an update on its differentiated strategy to excel in the growing cannabis [...]
Express Scripts Holding Company Announces Second Quarter 2018 Earnings Release Details
12/07/2018
St. Louis, July 12, 2018 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“ Express Scripts ”) announced today its intention to release its 2018 second quarter financial results on Wednesday, August 1 [...]
Xbrane and STADA enter into a co-development agreement for Xlucane
12/07/2018
Press release 2018-07-12 Xbrane Biopharma AB ("Xbrane") and STADA Arzneimittel AG ("STADA") have entered into a co-development agreement for Xlucane, a Lucentis ® (ranibizumab) biosimilar. About the agreement The [...]
NeuroMetrix, Inc. Announces Date for 2018 Second Quarter Financial Results Conference Call
12/07/2018
WALTHAM, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it plans to issue its 2018 second quarter financial results before the opening of the market on Thursday, July 19, [...]
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2018 Financial Results
12/07/2018
Conference Call Scheduled for July 19, 2018 at 11:00 am EASTERN DUBLIN, Ireland, July 12, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the [...]
Medtronic Wins Expanded Indication for SelectSecure(TM) MRI SureScan(TM) Pacing Lead for His Bundle Site Stimulation
12/07/2018
DUBLIN - July 12, 2018 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) labeling expansion for the Medtronic SelectSecure(TM) MRI SureScan(TM) Model 3830 cardiac pacing lead to include [...]
Cue Announces $30 Million Funding Contract from U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority
12/07/2018
SAN DIEGO, July 12, 2018 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare technology company, announced today that is has been awarded up to $30 million in base funding and options from the U.S. Department of [...]
CohBar Initiates Clinical Study with First-in-human Dosing of CB4211, a Novel Mitochondria Based Therapeutic for the Treatment of NASH
12/07/2018
MENLO PARK, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today announced [...]
SELLAS Life Sciences Announces Pricing of Upsized $24.2 Million Public Offering
12/07/2018
NEW YORK, July 12, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of novel cancer [...]
Marrone Bio Innovations to Host Virtual Roadshow Webinar on July 26th, 2018
12/07/2018
DAVIS, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf [...]
Cutera, Inc. to Announce Second Quarter 2018 Results
12/07/2018
BRISBANE, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. ( CUTR ) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, will announce [...]
Avinger Announces Pricing of $3.55 Million Registered Direct Offering
12/07/2018
REDWOOD CITY, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has entered into a [...]
Tauriga Sciences, Inc. on Track to Up-List its Shares to OTCQB Exchange at Open of Trading on July 30, 2018
12/07/2018
NEW YORK, NY, July 12, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) (OTC PINK: TAUGD) (“Tauriga” or the “Company”), engaged in building its business through the development, distribution, and [...]
WishBone Medical, Inc. announces Sanford S. Kunkel, M.D. joins Board of Advisors
12/07/2018
WARSAW, Ind., July 12, 2018 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. is pleased to announce that Sanford Kunkel, M.D. joins the WishBone Medical Board of Advisors. Dr. Kunkel has been a Consulting Surgeon for WishBone [...]
Catalyst Biosciences Announces Multiple Presentations at the Scientific and Standardization Committee Meeting of the International Society on Thrombosis and Haemostasis
12/07/2018
Conference call and webcast to be held Wednesday, July 18, 2018 at 8:30 a.m. EDT SOUTH SAN FRANCISCO, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), a clinical-stage [...]

Pages